跳至主要内容
临床试验/TCTR20231003001
TCTR20231003001已完成不适用

A Randomized Controlled Clinical Trial of Cordyceps militaris Beverage on the Immune Response

ational Innovation Agency (NIA)0 个研究点目标入组 40 人开始时间: 2023年10月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
25 Years 至 60 Years(—)
性别
All

入选标准

  • 1) Male and female adult participants aged 25-60 during the screening test.
  • 2) No history of hypersensitivity or idiosyncratic reactions to drugs or herbal products.
  • 3) Willing to participate in the project throughout the research program.

排除标准

  • 1) Participants diagnosed with immune-mediated disease, nervous system disorders, cardiovascular disease, or liver or kidney disease.
  • 2) Participants diagnosed with chronic health problems such as hypertension, diabetes, or renal failure, etc.
  • 3) A body mass index (BMI) greater than 29.9 or less than 18 kg/m2.
  • 4) Participants who were pregnant or lactating or intended to become pregnant during the trial period.
  • 5) Participants who, within two weeks, ingested a drug or functional food that may affect the immunomodulatory effect of the test product
  • 6) Participants who had an alanine transaminase (ALT) or aspartate transaminase (AST) plasma level more than three times the guideline of the organization.

研究者

发起方
ational Innovation Agency (NIA)

相似试验